11-108236770-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000051.4(ATM):​c.496+936T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.525 in 151,926 control chromosomes in the GnomAD database, including 21,788 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 21788 hom., cov: 31)

Consequence

ATM
NM_000051.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.385

Publications

6 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial ovarian cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.631 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.496+936T>G
intron
N/ANP_000042.3
ATM
NM_001351834.2
c.496+936T>G
intron
N/ANP_001338763.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.496+936T>G
intron
N/AENSP00000501606.1
ATM
ENST00000452508.7
TSL:1
c.496+936T>G
intron
N/AENSP00000388058.2
ATM
ENST00000531525.3
TSL:1
c.496+936T>G
intron
N/AENSP00000434327.3

Frequencies

GnomAD3 genomes
AF:
0.525
AC:
79758
AN:
151808
Hom.:
21777
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.376
Gnomad AMI
AF:
0.645
Gnomad AMR
AF:
0.617
Gnomad ASJ
AF:
0.641
Gnomad EAS
AF:
0.434
Gnomad SAS
AF:
0.649
Gnomad FIN
AF:
0.630
Gnomad MID
AF:
0.741
Gnomad NFE
AF:
0.568
Gnomad OTH
AF:
0.559
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.525
AC:
79792
AN:
151926
Hom.:
21788
Cov.:
31
AF XY:
0.534
AC XY:
39631
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.376
AC:
15561
AN:
41408
American (AMR)
AF:
0.617
AC:
9418
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.641
AC:
2224
AN:
3470
East Asian (EAS)
AF:
0.435
AC:
2241
AN:
5156
South Asian (SAS)
AF:
0.650
AC:
3135
AN:
4824
European-Finnish (FIN)
AF:
0.630
AC:
6652
AN:
10564
Middle Eastern (MID)
AF:
0.731
AC:
215
AN:
294
European-Non Finnish (NFE)
AF:
0.568
AC:
38576
AN:
67920
Other (OTH)
AF:
0.560
AC:
1182
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1839
3678
5518
7357
9196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.536
Hom.:
2881
Bravo
AF:
0.514
Asia WGS
AF:
0.569
AC:
1979
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.53
DANN
Benign
0.36
PhyloP100
-0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs228598; hg19: chr11-108107497; API